News
FDA granted an accelerated approval for Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Vanrafia can be ...
European countries must match ambition with action — and reward the kind of pharmaceutical innovation they say they want to lead.
Today, the National Institute for Health and Care Excellence (NICE) published its preliminary optimised recommendation 1 for ribociclib to be used as adjuvant treatment in combination with an ...
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Job Title Sort ascending Business Location Site Date Posted QC Analyst I Regular, Full time Innovative Medicines Singapore Tuas South Avenue Apr 24, 2025 Data Science Regular, Full time Corporate ...
An International, Prospective, Open-label, Multi-center, Randomized Phase III Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) Versus Observation to Delay Castration or Disease ...
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
While I didn’t love math in school, it was actually my worst subject. I enjoyed learning about the physics of flips. I focused on understanding rotational motion and momentum, which helped me to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results